MARKET

NGENF

NGENF

Nervgen Pharma Corp
OTCMQB
1.880
NaN%
Opening 09:30 03/20 EDT
OPEN
--
PREV CLOSE
1.880
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
2.420
52 WEEK LOW
1.280
MARKET CAP
133.09M
P/E (TTM)
-6.8739
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NGENF last week (0310-0314)?
Weekly Report · 3d ago
NervGen Pharma Grants Stock Options
Newsfile · 5d ago
Weekly Report: what happened at NGENF last week (0303-0307)?
Weekly Report · 03/10 12:17
NervGen Pharma to Present at Virtual Life Sciences Investor Forum
TipRanks · 03/05 14:09
NervGen Pharma to Present at the Virtual Life Science Investor Forum
Newsfile · 03/05 13:30
Weekly Report: what happened at NGENF last week (0224-0228)?
Weekly Report · 03/03 12:15
Weekly Report: what happened at NGENF last week (0217-0221)?
Weekly Report · 02/24 12:15
NervGen Pharma Aligns Employee Incentives with Stock Options Grant
TipRanks · 02/18 22:26
More
About NGENF
NervGen Pharma Corp. is a clinical-stage biotech company. The Company is engaged in discovery, development and commercialization of pharmaceutical products for the treatment of nervous system damage due to injury or disease. The Company is advancing its lead compound, NVG-291, for the treatment of spinal cord injury (SCI), Alzheimer’s disease (AD) and multiple sclerosis (MS). Its NVG-291 is a therapeutic peptide, which is a mimetic of the intracellular domain of protein tyrosine phosphatase, a cell surface receptor known to interact with chondroitin sulfate proteoglycans (CSPGs) and to be involved in the regulation of neuroplasticity and central nervous system repair. It has also initiated preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury. The Company's wholly owned subsidiaries include NervGen US Inc. and NervGen Australia Pty Ltd.

Webull offers NervGen Pharma Corp stock information, including OTCMQB: NGENF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NGENF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NGENF stock methods without spending real money on the virtual paper trading platform.